Intention-to-treat approach to data from randomized controlled trials: A sensitivity analysis

被引:127
作者
Wright, CC
Sim, J
机构
[1] Coventry Univ, Sch Hlth & Social Sci, Coventry CV1 5FB, W Midlands, England
[2] Keele Univ, Primary Care Sci Res Ctr, Keele, Staffs, England
关键词
randomized controlled trials; intention-to-treat analysis; imputation; sensitivity analysis;
D O I
10.1016/S0895-4356(03)00155-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The intention-to-treat (ITT) approach to randomized controlled trials analyzes data on the basis of treatment assignment, not treatment receipt. Alternative approaches make comparisons according to the treatment received at the end of the trial (as-treated analysis) or using only subjects who did not deviate from the assigned treatment (adherers-only analysis). Using a sensitivity analysis on data for a hypothetical trial, we compare these different analytical approaches in the context of two common protocol deviations: loss to follow-up and switching across treatments. In each case, two rates of deviation are considered: 10% and 30%. The analysis shows that biased estimates of effect may occur when deviation is nonrandom, when a large percentage of participants switch treatments or are lost to follow-up, and when the method of estimating missing values accounts inadequately for the process causing loss to follow-up. In general, ITT analysis attenuates between-group effects. Trialists should use sensitivity analyses on their data and should compare the characteristics of participants who do and those who do not deviate from the trial protocol. The ITT approach is not a remedy for unsound design, and imputation of missing values is not a substitute for complete, good quality data. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:833 / 842
页数:10
相关论文
共 37 条
[1]  
Allison P., 2002, MISSING DATA
[2]  
Altman DG, 1990, PRACTICAL STAT MED R
[3]  
[Anonymous], QUALITY LIFE ASSESSM
[4]  
Armitage P., 2002, STAT METHODS MED RES
[5]   Ruminations on the intent-to-treat principle [J].
Begg, CB .
CONTROLLED CLINICAL TRIALS, 2000, 21 (03) :241-243
[6]   Intention-to-treat vs. on-treatment analyses of clinical trial data:: Experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients [J].
Chêne, G ;
Morlat, P ;
Leport, C ;
Hafner, R ;
Dequae, L ;
Charreau, I ;
Aboulker, JP ;
Luft, B ;
Aubertin, J ;
Vildé, JL ;
Salamon, R .
CONTROLLED CLINICAL TRIALS, 1998, 19 (03) :233-248
[7]  
Everitt B., 1994, STAT METHODS MED INV
[8]  
Fisher LD., 1990, Statistical Issues in Drug Research and Development
[9]   Intention-to-treat analysis in randomized trials: Who gets counted? [J].
Gibaldi, M ;
Sullivan, S .
JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (08) :667-672
[10]  
GILLINGS D, 1991, DRUG INF J, V25, P411, DOI DOI 10.1177/009286159102500311